Manpower Demonstration Research Corporation (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
162
Publications
2033
Citations
126309
i10-index
966
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Antiinflammatory Therapy with Canakinumab for Athe... | 2017 | 9200 |
Cardiovascular Risk Reduction with Icosapent Ethyl... | 2018 | 3265 |
From Vulnerable Plaque to Vulnerable Patient | 2003 | 2672 |
From Vulnerable Plaque to Vulnerable Patient | 2003 | 2257 |
Effects of Dalcetrapib in Patients with a Recent A... | 2012 | 2040 |
Effect of Very High-Intensity Statin Therapy on Re... | 2006 | 2040 |
Triglycerides and Cardiovascular Disease | 2011 | 1871 |
Efficacy and Safety of Evolocumab in Reducing Lipi... | 2015 | 1496 |
Circulating Adhesion Molecules VCAM-1, ICAM-1, and... | 1997 | 1350 |
Effect of interleukin-1β inhibition with canakinum... | 2017 | 1318 |
Christie M. Ballantyne is a researcher with 2033 publications and 126309 citations. They are affiliated with Manpower Demonstration Research Corporation. Their research focuses on . With an h-index of 162, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Christie M. Ballantyne and 250M+ other papers.
Citations per publication by year